CeriBell (CBLL) Stock Overview
Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CBLL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CeriBell, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$21.30 |
| 52 Week High | US$26.04 |
| 52 Week Low | US$10.01 |
| Beta | 0 |
| 1 Month Change | 18.33% |
| 3 Month Change | 68.51% |
| 1 Year Change | -12.31% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -14.80% |
Recent News & Updates
Recent updates
Analysts Have Been Trimming Their CeriBell, Inc. (NASDAQ:CBLL) Price Target After Its Latest Report
Nov 07
Does CeriBell (NASDAQ:CBLL) Have A Healthy Balance Sheet?
Oct 30CeriBell, Inc. (NASDAQ:CBLL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 08CeriBell: An EEG Concern Posting Impressive Growth
Jun 13CeriBell: A Leader In AI-Powered Seizure Detection
Feb 21CeriBell: Healthcare Technology Stock With A Promising Growth Outlook
Nov 20CeriBell: An Interesting EEG Play Going Public
Oct 21Shareholder Returns
| CBLL | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -1.1% |
| 1Y | -12.3% | 2.4% | 14.7% |
Return vs Industry: CBLL underperformed the US Medical Equipment industry which returned 2.9% over the past year.
Return vs Market: CBLL underperformed the US Market which returned 14.6% over the past year.
Price Volatility
| CBLL volatility | |
|---|---|
| CBLL Average Weekly Movement | 8.5% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBLL has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: CBLL's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 281 | Jane Chao | www.ceribell.com |
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband.
CeriBell, Inc. Fundamentals Summary
| CBLL fundamental statistics | |
|---|---|
| Market cap | US$813.51m |
| Earnings (TTM) | -US$52.46m |
| Revenue (TTM) | US$82.81m |
Is CBLL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBLL income statement (TTM) | |
|---|---|
| Revenue | US$82.81m |
| Cost of Revenue | US$9.94m |
| Gross Profit | US$72.87m |
| Other Expenses | US$125.33m |
| Earnings | -US$52.46m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.41 |
| Gross Margin | 87.99% |
| Net Profit Margin | -63.35% |
| Debt/Equity Ratio | 12.0% |
How did CBLL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/02 03:11 |
| End of Day Share Price | 2026/01/02 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CeriBell, Inc. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Travis Steed | BofA Global Research |
| Marie Thibault | BTIG |